IGC Pharma, Inc. (IGC)
0.3063
0.00 (0.00%)
USD |
NYAM |
Aug 26, 15:55
IGC Pharma 1 Year Total Returns (Daily) : -18.43% for Aug. 25, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 25, 2026 | -18.43% |
| August 24, 2026 | -17.64% |
| August 21, 2026 | -12.40% |
| August 20, 2026 | -22.79% |
| August 19, 2026 | -23.20% |
| August 18, 2026 | -25.18% |
| August 17, 2026 | -24.30% |
| August 14, 2026 | -17.28% |
| August 13, 2026 | -17.25% |
| August 12, 2026 | -17.20% |
| August 11, 2026 | -20.40% |
| August 10, 2026 | -21.21% |
| August 07, 2026 | -24.31% |
| August 06, 2026 | -27.50% |
| August 05, 2026 | -27.63% |
| August 04, 2026 | -28.61% |
| August 03, 2026 | -28.21% |
| July 31, 2026 | -30.83% |
| July 30, 2026 | -31.04% |
| July 29, 2026 | -35.14% |
| July 28, 2026 | -31.52% |
| July 27, 2026 | -28.18% |
| July 24, 2026 | -28.38% |
| July 23, 2026 | -33.57% |
| July 22, 2026 | -34.17% |
| Date | Value |
|---|---|
| July 21, 2026 | -27.81% |
| July 20, 2026 | -25.38% |
| July 17, 2026 | -23.33% |
| July 16, 2026 | -23.29% |
| July 15, 2026 | -21.11% |
| July 14, 2026 | -28.74% |
| July 13, 2026 | -30.17% |
| July 10, 2026 | -34.46% |
| July 09, 2026 | -23.77% |
| July 08, 2026 | -13.38% |
| July 07, 2026 | -12.39% |
| July 06, 2026 | -7.11% |
| July 02, 2026 | -8.50% |
| July 01, 2026 | -9.49% |
| June 30, 2026 | -11.11% |
| June 29, 2026 | -12.30% |
| June 26, 2026 | -15.16% |
| June 25, 2026 | -14.83% |
| June 24, 2026 | -12.97% |
| June 23, 2026 | -13.23% |
| June 22, 2026 | -11.87% |
| June 18, 2026 | -8.06% |
| June 17, 2026 | -8.10% |
| June 16, 2026 | -6.88% |
| June 15, 2026 | -6.53% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Cocrystal Pharma, Inc. | -26.62% |
| CNBX Pharmaceuticals, Inc. | -62.50% |
| GB Sciences, Inc. | 50.00% |
| Arvinas, Inc. | 28.34% |
| Fulcrum Therapeutics, Inc. | -39.78% |